Vetoquinol: after a mixed year, the outlook is improving
The animal health specialist suffered in 2022, but the accounts and the new strategic plan were well received. Vetoquinol’s annual turnover was 5% below consensus expectations at 521 million euros, down 0.8% organically, slowed down by a third and final quarter with respective declines of 4.5 and 2.4%, causing the stock to fall. The publication […]
Vetoquinol: after a mixed year, the outlook is improving Read More »